on 23 Jul 2024
Last Applicant/ Owned by
Rehovot
IL
Serial Number
79347817 filed on 27th Mar 2022
Registration Number
7451851 registered on 23rd Jul 2024
Correspondent Address
Jeffrey A. Smith
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; chemicals for use in organ transplantation, namely, chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; bio-chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; bio-chemicals for use in organ transplantation, namely, Read More
Biological preparations for use in pharmaceutical, medical and veterinary industry, namely, for personalized medicine use in the nature of treatment of autoimmune diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, microbial disorders and diseases, fungal disorders and diseases, inflammatory disorders and diseases, vaginal and rectal disorders and diseases, ear and eye disorders, orthopedic diseases and disorders, central and peripheral nervous system diseases and disorders, endocrine system diseases and disorders, neurodegenerative diseases and disorders, nasal pharyngeal diseases and disorder, cancer, infectious diseases and viral infections; bioadhesives, namely, medical adhesives intended for closure of wounds and gaps and for other medical fixing, namely, binding internal tissue; bio-printed materials for use in organ transplantation, namely, biological soft, hard, skin and bone tissue grafts and cultures, implantable scaffolds comprised of living tissue or cells, organ implants comprised of living tissue or cells, intended for subsequent implantation, and bio-inks comprised of living cells which stimulates tissue regeneration and support cell adherence and proliferation for medical use; biological implants, namely, biological soft and hard human connective tissue intended for subsequent implantation and organ implants comprised of living tissue or cells, intended for subsequent implantation; biological preparations for use in cell culture applications in the fields of pharmaceutical, medical, veterinary and aesthetic medicine use, namely, cell culture media for cultivating animal or human tissue or cells
N/A
N/A
Chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; chemicals for use in organ transplantation, namely, chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; bio-chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; bio-chemicals for use in organ transplantation, namely, bio-chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; biological preparations for use in industry and science, other than for medical, veterinary, cosmetics or aesthetic use; biological preparations for use in cosmetics and aesthetic industry; biological preparations for use in industry, namely, bio-printable materials in the nature of cells and bio-inks being bio-chemicals for use in cosmetics and aesthetic industries, not for medical use or veterinary purposes; biological preparations for use in cell cultures for applications in the field of cosmetics, not for medical or veterinary use
N/A
N/A
No 79347817
No Service/Collective Mark
No EHRLICH0007T
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
04th Jan 2025 | FINAL DISPOSITION PROCESSED |
04th Jan 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
23rd Oct 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
23rd Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
23rd Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
07th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
07th May 2024 | PUBLISHED FOR OPPOSITION |
07th May 2024 | NOTIFICATION PROCESSED BY IB |
17th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
17th Apr 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |